Thomas Malfait
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas Malfait has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Annelies Aerssens
Department of Infection Control, Ghent University Hospital, Ghent, Belgium
1 shared publication Bruno Verhasselt
Ghent University Hospital, Department of Medical Microbiology, Gent, Belgium
1 shared publication- Bruno Verhasselt
Department of Diagnostic Sciences, Faculty of Medicine and Life Sciences, Ghent University
1 shared publication Dieter Stevens
Ghent University Hospital, Department of Respiratory Medicine, Gent, Belgium
1 shared publicationElizaveta Padalko
Ghent University Hospital, Department of Medical Microbiology, Gent, Belgium
1 shared publication- Elizaveta Padalko
Ghent University Hospital
1 shared publication
Latest Publications
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Late Breaking Abstract - The role of bronchoscopy in COVID-19 patients during the SARS-CoV-2 pandemic
Background: During the SARS-CoV-2 pandemic, rapid and reliable diagnosis of COVID-19 is paramount for clinical and infection control reasons. Real-time reverse transcriptase–polymerase chain reaction (rRT-PCR) is considered the gold standard to confirm clinical suspicion. Nasopharyngeal swab (NFS) is commonly used but bronchoalveolar lavage (BAL) specimens show the highest positivity rates of rRT-PCR. Due to its aerosol-generating characteristics, it is advised to postpone bronchoscopy to avoid contamination of healthcare workers. Therefore, little is known about its diagnostic value. Objective: To assess the added diagnostic value of bronchoscopy in COVID-19 patients. Methods: A retrospective analysis of added diagnostic certainty of bronchoscopies carried out at Ghent University Hospital during the epidemic peak in Belgium. Rule in/rule out [Ri/Ro] bronchoscopies in patients with diagnostic uncertainty (repetitive negative NSF swab but high clinical suspicion for COVID-19) were withheld, as well as bronchoscopies in known COVID-19 [Cov+] but suspicious of alternative pathology. Results: Of 31 bronchoscopies performed for diagnostic uncertainty between 19/3 and 30/4/2020, 29 yielded additional diagnostic certainty. Of 26 [Ri/Ro] patients, BAL revealed rRT-PCR positivity in 7, confirmed rRT-PCR negativity in 7 and yielded an alternative microbiological diagnosis in 12. Of 5 [Cov+] patients, 3 had additional microbiological diagnosis. No bronchoscopy-related adverse events or transmission towards involved staff was reported. Conclusion: In suspected COVID-19 cases with diagnostic uncertainty bronchoscopy has an additional diagnostic value with therapeutic consequences provided safety standards are ensured.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Late Breaking Abstract - The role of bronchoscopy in COVID-19 patients during the SARS-CoV-2 pandemic
Background: During the SARS-CoV-2 pandemic, rapid and reliable diagnosis of COVID-19 is paramount for clinical and infection control reasons. Real-time reverse transcriptase–polymerase chain reaction (rRT-PCR) is considered the gold standard to confirm clinical suspicion. Nasopharyngeal swab (NFS) is commonly used but bronchoalveolar lavage (BAL) specimens show the highest positivity rates of rRT-PCR. Due to its aerosol-generating characteristics, it is advised to postpone bronchoscopy to avoid contamination of healthcare workers. Therefore, little is known about its diagnostic value. Objective: To assess the added diagnostic value of bronchoscopy in COVID-19 patients. Methods: A retrospective analysis of added diagnostic certainty of bronchoscopies carried out at Ghent University Hospital during the epidemic peak in Belgium. Rule in/rule out [Ri/Ro] bronchoscopies in patients with diagnostic uncertainty (repetitive negative NSF swab but high clinical suspicion for COVID-19) were withheld, as well as bronchoscopies in known COVID-19 [Cov+] but suspicious of alternative pathology. Results: Of 31 bronchoscopies performed for diagnostic uncertainty between 19/3 and 30/4/2020, 29 yielded additional diagnostic certainty. Of 26 [Ri/Ro] patients, BAL revealed rRT-PCR positivity in 7, confirmed rRT-PCR negativity in 7 and yielded an alternative microbiological diagnosis in 12. Of 5 [Cov+] patients, 3 had additional microbiological diagnosis. No bronchoscopy-related adverse events or transmission towards involved staff was reported. Conclusion: In suspected COVID-19 cases with diagnostic uncertainty bronchoscopy has an additional diagnostic value with therapeutic consequences provided safety standards are ensured.
- Open Access
Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR
Background: Early 2020, a COVID-19 epidemic became a public health emergency of international concern. To address this pandemic broad testing with an easy, comfortable and reliable testing method is of utmost concern. The nasopharyngeal (NP) swab sampling is the reference method though hampered by international supply shortages. A new oropharyngeal/nasal (OP/N) sampling method was investigated using the more readily available throat swab. Methods: In this prospective observational study 36 COVID-19 patients were tested with both a NP and combined OP/N swab for SARS-CoV-2 RNA by PCR. In hospitalized suspect patients, who tested negative on both swabs, extensive retesting was performed. The sensitivity of NP versus combined OP/N swab sampling on admission and the correlation between viral RNA loads recovered was investigated. Results: 35 patients were diagnosed with SARS-CoV-2 by means of either NP or OP/N sampling. The paired swabs were both positive in 31 patients. The one patient who tested negative on both NP and OP/N swab on admission, was ultimately diagnosed on bronchoalveolar lavage fluid. A strong correlation was found between the viral RNA loads of the paired swabs (r = 0.76; P < 0.05). The sensitivity of NP and OP/N analysis in hospitalized patients (n = 28) was 89.3% and 92.7% respectively. Conclusions: This study demonstrates equivalence of NP and OP/N sampling for detection of SARS-CoV-2 by means of rRT-PCR. Sensitivity of both NP and OP/N sampling is very high in hospitalized patients.
Open AccessCombined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR
Background: Early 2020, a COVID-19 epidemic became a public health emergency of international concern. To address this pandemic broad testing with an easy, comfortable and reliable testing method is of utmost concern. The nasopharyngeal (NP) swab sampling is the reference method though hampered by international supply shortages. A new oropharyngeal/nasal (OP/N) sampling method was investigated using the more readily available throat swab. Methods: In this prospective observational study 36 COVID-19 patients were tested with both a NP and combined OP/N swab for SARS-CoV-2 RNA by PCR. In hospitalized suspect patients, who tested negative on both swabs, extensive retesting was performed. The sensitivity of NP versus combined OP/N swab sampling on admission and the correlation between viral RNA loads recovered was investigated. Results: 35 patients were diagnosed with SARS-CoV-2 by means of either NP or OP/N sampling. The paired swabs were both positive in 31 patients. The one patient who tested negative on both NP and OP/N swab on admission, was ultimately diagnosed on bronchoalveolar lavage fluid. A strong correlation was found between the viral RNA loads of the paired swabs (r = 0.76; P < 0.05). The sensitivity of NP and OP/N analysis in hospitalized patients (n = 28) was 89.3% and 92.7% respectively. Conclusions: This study demonstrates equivalence of NP and OP/N sampling for detection of SARS-CoV-2 by means of rRT-PCR. Sensitivity of both NP and OP/N sampling is very high in hospitalized patients.
- Open Access
- 30 September 2010
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 36 (4) , 965-967
Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer
- 30 September 2010
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 36 (4) , 965-967
Open AccessEndobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer